HALO logo
600812
North China Pharmaceutical Company Ltd. Class A

600812 · North China Pharmaceutical Company Ltd. Class A

6.26

CNY
-0.31 (-4.718%)
16/10/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Yuan10.71B

PE

51.80

EV/EBITDA

13.3

DIV Yield

0.6%

Payout Ratio

33%

MQV Rating

5Very Weak

As at 16/10/2026 12:00:00 AM

Price Chart

Description

North China Pharmaceutical Co., Ltd. engages in the research, development, production and sales of pharmaceutical products. It offers chinese and western medicines, antibiotics, vitamins, agricultural, biotechnology products, veterinary drugs, general freight and technical consulting services. The company was founded on August 25, 1992 and is headquartered in Shijiazhuang, China.

  • All-Companies
  • Big Candle
  • HALO All
  • HALO Price Momentum
  • Near 52 Week High
  • Near Resistance
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

-126.60%

EBITDA Margin

17.20%

Operating Cashflow

¥1,237m

Free Cash Flow Return

14.90%

ROIC

2.20%

Interest Coverage

4.30

Quick Ratio

0.50

Performance

52 weeks range

Low 4.11 - 6.63

Trade Value (12mth)

US$5,190,705.00

1 week

19.89%

1 month

36.87%

YTD

17.74%

1 year

12.69%

All time high

20.24

Additional Data

Shares Outstanding (Fully Diluted)

1,716m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

11-Jun-26

Next Dividend Pay Date

11-Jun-26

Reporting Currency

CNY

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of North China Pharmaceutical Company Ltd. Class A (600812:SHG)?
Halo FAQ
The current share price of North China Pharmaceutical Company Ltd. Class A (600812:SHG) is CNY¥6.26.
2
What is the 52-week high share price for North China Pharmaceutical Company Ltd. Class A (600812:SHG)?
Halo FAQ
The 52-week high share price for North China Pharmaceutical Company Ltd. Class A (600812:SHG) is CNY¥6.63.
3
What is the 52-week low share price for North China Pharmaceutical Company Ltd. Class A (600812:SHG)?
Halo FAQ
The 52-week low share price for North China Pharmaceutical Company Ltd. Class A (600812:SHG) is CNY¥4.11.
4
What is the dividend yield for North China Pharmaceutical Company Ltd. Class A (600812:SHG)?
Halo FAQ
The current TTM dividend payout for North China Pharmaceutical Company Ltd. Class A (600812:SHG) is 0.60.
5
What was North China Pharmaceutical Company Ltd. Class A (600812:SHG) last dividend payment?
Halo FAQ
The last dividend payment of North China Pharmaceutical Company Ltd. Class A (600812:SHG) is CNY¥0.04.
6
What is the franking level for North China Pharmaceutical Company Ltd. Class A (600812:SHG)?
Halo FAQ
North China Pharmaceutical Company Ltd. Class A (600812:SHG) has a franking level of 0.00%.
7
In which sector is North China Pharmaceutical Company Ltd. Class A (600812:SHG) classified?
Halo FAQ
North China Pharmaceutical Company Ltd. Class A (600812:SHG) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for North China Pharmaceutical Company Ltd. Class A (600812:SHG)?
Halo FAQ
The current P/E ratio for North China Pharmaceutical Company Ltd. Class A (600812:SHG) is 51.80.